CRYSTAL SALAZAR: Open Payments
NPI 1710139308 · LAKEWAY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 39 payments from 8 companies in 2025. Trend: 2023 $1,162 · 2024 $854 · 2025 $740
Food & beverage: $642Education: $98
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 10 | $193 |
| GlaxoSmithKline, LLC. | 11 | $171 |
| GENZYME CORPORATION | 5 | $115 |
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| Novartis Pharmaceuticals Corporation | 3 | $61 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $57 |
| Organon LLC | 2 | $34 |
| Inspire Medical Systems, Inc. | 1 | $32 |
Products named: DUPIXENT, TRELEGY ELLIPTA, NEFFY, TEZSPIRE, INSPIRE, Rhapsido, AIRSUPRA, FASENRA.
Industry payments across TX — which companies pay providers there.
